Xiao-Bin Zheng
Overview
Explore the profile of Xiao-Bin Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
362
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Liu X, Wu X, Lan N, Zheng X, Zhou C, Hu T, et al.
Oncol Lett
. 2020 Jul;
20(2):1221-1230.
PMID: 32724362
Patients with inflammatory bowel disease (IBD) are at a higher risk of developing colitis-associated colorectal cancer. The aim of the present study was to investigate the role of CD73 in...
12.
A Novel Oncogenic Driver in a Lung Adenocarcinoma Patient Harboring an -KDD and Response to Afatinib
Chen D, Li X, Wu B, Zheng X, Wang W, Chen H, et al.
Front Oncol
. 2020 Jul;
10:867.
PMID: 32656077
Oncogenic mutations in the epidermal growth factor receptor () occur frequently in patients with lung cancer. These mutations may serve as critical predictive biomarkers in patients with non-small cell lung...
13.
Zhou C, Liu H, Wang F, Hu T, Liang Z, Lan N, et al.
Mol Ther
. 2020 Jan;
28(3):914-928.
PMID: 31951832
Increasing studies indicated that circular RNAs (circRNAs) play important roles in cancer progression. However, the roles of circRNAs in colorectal cancer (CRC) remain largely unknown. In this study, we determined...
14.
Zhou C, Wu X, Liu H, Liu X, Liu G, Zheng X, et al.
J Crohns Colitis
. 2019 Dec;
14(5):654-668.
PMID: 31841595
Background And Aims: Despite the therapeutic promise of stem cell therapy in the treatment of inflammatory bowel diseases [IBD], most donor cell populations have to be obtained via invasive approaches...
15.
Zhou C, Liu H, Liu X, Zheng X, Hu T, Liang Z, et al.
Ann Transl Med
. 2019 Dec;
7(20):543.
PMID: 31807525
Background: Currently, reliable approaches for accurate assessment of lymph node metastases (LNM), which is an important indication of preoperative chemoradiotherapy (CRT), are not available for clinically node-negative rectal cancer patients....
16.
Xiao Y, Zhou C, Ye J, Yang X, Li Z, Zheng X, et al.
ACS Omega
. 2019 Oct;
4(13):15560-15566.
PMID: 31572857
Colorectal cancer (CRC) is the third most common cancer and the fourth leading cause of cancer deaths worldwide. Integrin α6 is overexpressed in all stages of CRC which makes it...
17.
Wang Q, Li S, Zhao Y, Dai D, Du H, Lin Y, et al.
J Control Release
. 2019 Aug;
311-312:324-325.
PMID: 31447187
No abstract available.
18.
Xie R, Fang X, Zheng X, Lv W, Li Y, Rage H, et al.
Biomed Pharmacother
. 2019 Jul;
118:109175.
PMID: 31351423
Increasing research indicates that hyperglycemia plays a crucial role in the progression of diabetic nephropathy (DN); however, effective treatment for preventing or slowing DN progression are seriously lacking. Although salidroside...
19.
Zheng X, He X, Zhang L, Qin H, Lin X, Liu X, et al.
Gastroenterol Rep (Oxf)
. 2019 Apr;
7(2):127-138.
PMID: 30976426
Background And Objective: Increasing interest has developed in the therapeutic potential of bone marrow-derived mesenchymal stem cells (MSCs) for the treatment of inflammatory bowel disease (IBD) and IBD-induced cancer. However,...
20.
Wu X, Zheng X, Huang Y, Cao Q, Zhang H, Miao Y, et al.
Gastroenterol Rep (Oxf)
. 2019 Feb;
7(1):67-73.
PMID: 30792868
Background: This study sought to evaluate the risk factors for the development of colitis-associated neoplasia (CAN) in Chinese patients with inflammatory bowel disease (IBD). Methods: IBD patients who developed CAN...